FONTAN
Clinical trials for FONTAN explained in plain language.
Never miss a new study
Get alerted when new FONTAN trials appear
Sign up with your email to follow new studies for FONTAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes pill boost heart health in fontan patients?
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug already approved for diabetes and heart failure, can improve exercise ability and heart function in people who have had the Fontan procedure. About 30 participants aged 12 and older will take the drug daily for 3 months. The goal is …
Matched conditions: FONTAN
Phase 4 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
New test could spot liver trouble early in fontan patients
Knowledge-focused Recruiting nowThis study is testing a new way to measure liver function in adults who have had the Fontan procedure, a surgery for certain heart defects. Researchers will use a dual cholate clearance test (a special blood test) and a heart MRI to see how well the liver is working. They will co…
Matched conditions: FONTAN
Sponsor: HepQuant, LLC • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Heart drug hope: diabetes meds may help adults born with heart defects
Knowledge-focused Recruiting nowThis international registry is tracking 400 adults with congenital heart disease who are taking SGLT2 inhibitors, a type of diabetes medication that also benefits the heart. Researchers want to see how these drugs are being prescribed, how well they are tolerated, and whether the…
Matched conditions: FONTAN
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC